Skip to content

AstraZenca vaccine

Press/Media: Expert Comment

Description

Simon Kolstoe comments on the number of European countries no longer administering the AstraZeneca vaccine following reports of blood clots

Period16 Mar 2021

References

TitleAbsolute Radio
Degree of recognitionNational
Media name/outletAbsolute Radio
Media typeRadio
CountryUnited Kingdom
Date16/03/21
DescriptionSimon Kolstoe comments on the number of European countries no longer administering the AstraZeneca vaccine following reports of blood clots
URLtiny.cc/iwqutz
PersonsSimon Kolstoe
TitleMagic Radio
Degree of recognitionNational
Media name/outletMagic Radio
Media typeRadio
CountryUnited Kingdom
Date16/03/21
DescriptionSimon Kolstoe comments on the number of European countries no longer administering the AstraZeneca vaccine following reports of blood clots
URLtiny.cc/lwqutz
PersonsSimon Kolstoe
TitleRock FM
Degree of recognitionRegional
Media name/outletRock FM
Media typeRadio
CountryUnited Kingdom
Date16/03/21
DescriptionSimon Kolstoe comments on the number of European countries no longer administering the AstraZeneca vaccine following reports of blood clots
URLtiny.cc/rwqutz
PersonsSimon Kolstoe
TitleWave 105
Degree of recognitionNational
Media name/outletWave 105
Media typeRadio
CountryUnited Kingdom
Date16/03/21
DescriptionSimon Kolstoe comments on the number of European countries no longer administering the AstraZeneca vaccine following reports of blood clots
URLtiny.cc/swqutz
PersonsSimon Kolstoe
TitleIs there any substance behind the AstraZeneca vaccine doubts?
Degree of recognitionInternational
Media name/outletEuroNews
Media typeWeb
CountryFrance
Date16/03/21
DescriptionDenmark and Norway have suspended use of AstraZeneca's COVID-19 vaccine amid reports of blood clotting in some people who received the jab.

Health authorities said it was a step taken as a "precaution" with no direct link yet between the clots and the jab.

But it's yet more negative publicity for AstraZeneca, the Swedish-British multinational pharmaceutical company, already under the spotlight over vaccine production delays and the efficacy of its jab, which is produced with the University of Oxford.
Producer/AuthorLauren Chadwick
URLhttps://www.euronews.com/2021/03/13/is-there-any-substance-behind-the-astrazeneca-vaccine-doubts
PersonsSimon Kolstoe

Related information

Relations

ID: 26773596